Yossi Tzur

McGill University, Jewish General Hospital

Papers

2

Total Citations

9

H-Index

1

About

Yossi Tzur is a clinical researcher whose work sits at the intersection of gynecologic oncology and metabolic health, with a particular focus on how obesity shapes cancer outcomes and surgical decision-making. In a landmark 2024 predictors-matched case-control study, Tzur demonstrated that elevated BMI is independently associated with poorer survival in epithelial ovarian cancer—even after accounting for stage, histology, and comorbidities—a finding that challenges assumptions about obesity as a mere confounder and carries direct implications for risk stratification and treatment planning. More recently, Tzur has turned attention to endometrial intraepithelial neoplasia (EIN), investigating how obesity impacts sentinel lymph node mapping during robotic surgery. This work addresses a critical clinical debate: whether lymph node assessment in EIN can safely guide adjuvant therapy and avoid unnecessary re-staging procedures. With over 8 citations on the ovarian cancer study alone, Tzur’s contributions are already shaping practice patterns. By bridging surgical oncology, metabolic epidemiology, and precision staging, Tzur is helping to define a new standard of care for patients whose body habitus has too often been overlooked in cancer research.

Research Focus

Key Achievements

1
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: McGill University, Jewish General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago